Understanding Topical Corticosteroids
Topical corticosteroids (TCS), often referred to as topical steroids, are a cornerstone in the treatment of many inflammatory skin conditions. These medications contain synthetic versions of glucocorticoids, which are steroid hormones naturally produced by the adrenal glands. Glucocorticoids play a crucial role in the body's anti-inflammatory and immune-regulating processes [5]. When applied to the skin, TCS work by reducing inflammation, redness, itching, and swelling associated with various dermatological issues [5].
TCS are available in different potencies, ranging from mild to very potent, and come in various formulations such as creams, ointments, lotions, and solutions. The choice of potency and formulation depends on the specific skin condition, its severity, the location on the body, and the patient's age [1, 3].
Efficacy in Managing Skin Inflammation
Topical corticosteroids are highly effective for a wide array of inflammatory skin disorders. For conditions like psoriasis and eczema, including atopic eczema, TCS have demonstrated significant therapeutic benefits [1, 3, 7]. For example, clobetasol-17-propionate, one of the most potent topical steroids available, has shown superior efficacy compared to less potent steroids in treating psoriasis and various eczemas [1].
Another example, methylprednisolone aceponate (MPA), provides rapid and effective treatment for eczematous disorders, including those affecting the face and scalp, and has shown promise in treating psoriasis [3]. Hydrocortisone 17-butyrate is also effective for psoriasis, eczema, and other inflammatory dermatoses, with efficacy comparable to other commonly used topical corticosteroids like triamcinolone acetonide and betamethasone 17-valerate [7]. Their ability to reduce inflammation and symptoms makes them invaluable tools in dermatology.
Addressing Potential Side Effects
While highly effective, concerns about the safety of topical corticosteroids, particularly with long-term or inappropriate use, are common. Potential side effects include skin thinning (atrophy) and, less commonly, systemic effects like adrenal suppression [2, 5].
- Skin Thinning (Atrophy): This is a frequently discussed concern. An umbrella review summarizing safety data for TCS in atopic eczema found no meta-analyses specifically on skin thinning [2]. However, two randomized controlled trials (RCTs) lasting two weeks found no significant increased risk of skin thinning even with very potent TCS in children (0/196 TCS vs 0/33 vehicle) and adults (6/109 TCS vs 2/50 vehicle) [2]. This suggests that short-term, appropriate use may not lead to noticeable skin thinning. Prolonged and unsupervised use of potent fluorinated topical corticosteroids, however, has been linked to issues like atrophy, rosacea, and perioral dermatitis [7].
- Adrenal Suppression: This occurs when the body's natural production of cortisol is suppressed due to absorption of the steroid through the skin. A meta-analysis of 11 uncontrolled observational studies involving 522 children using various potencies of TCS for atopic eczema reported biochemical adrenal suppression in 3.8% of cases (95% CI 2.4% to 5.8%) [2]. This indicates it is a possible, though not extremely common, side effect, particularly in children.
- Rebound Eruption: Some topical steroids, such as hydrocortisone 17-butyrate, have been associated with a moderate rebound eruption in about 10% of patients upon discontinuation, especially when used on facial lesions [7].
- Misuse and Fungal Infections: Widespread misuse of topical corticosteroids can lead to serious complications, such as steroid-modified tinea (tinea incognito). This is a chronic, treatment-resistant fungal infection that can arise when steroids are used inappropriately on fungal infections, masking symptoms and making them harder to treat [6].
Strategies for Minimizing Risks and Safe Use
To maximize the benefits of topical corticosteroids while minimizing potential risks, dermatologists emphasize specific usage strategies:
- Intermittent Treatment: Using TCS on an intermittent schedule can help prolong remission rates and reduce the likelihood of side effects [1]. This approach involves using the medication for a set period, then taking a break, or using it only a few times a week.
- Appropriate Potency and Formulation: Selecting the correct potency and formulation for the specific condition and body area is crucial. For instance, methylprednisolone aceponate (MPA) is available in various forms (cream, ointment, fatty ointment, milk, solution), allowing for tailored treatment [3].
- Once-Daily Application: Some newer formulations, like MPA, offer the advantage of once-daily application without compromising efficacy, which can improve patient compliance and potentially enhance safety [3].
- Avoiding Misuse: It is critical to use TCS only for diagnosed inflammatory conditions and not for undiagnosed rashes or suspected fungal infections, as misuse can lead to more complex problems like tinea incognito [6]. Topical antibiotics, for instance, often add little benefit to topical corticosteroids alone for "infected eczema" that doesn't require systemic treatment [4].
Special Considerations for Children and Sensitive Areas
The safety of topical corticosteroids in children and on sensitive skin areas like the face is a common concern. Certain TCS, such as methylprednisolone aceponate (MPA), are considered particularly suitable for use in children and infants due to their rapid efficacy and excellent local and systemic tolerability [3].
For facial lesions, hydrocortisone 17-butyrate may be suitable for long-term use, though the potential for rebound eruption should be considered [7]. The umbrella review on atopic eczema, which included data on children, did not find a significant increased risk of skin thinning in short-term trials with very potent TCS [2]. This highlights that with careful selection and supervision, TCS can be safely used in pediatric populations and on delicate skin.
The Importance of Medical Guidance
Given the varying potencies, formulations, and potential side effects, the proper use and safe discontinuation of topical corticosteroids are essential [5]. Patients should always follow their healthcare provider's instructions regarding the type of steroid, application frequency, duration of treatment, and areas of application. Self-medicating or using leftover prescriptions can lead to ineffective treatment, worsening of conditions, or the development of adverse effects. Regular follow-up with a dermatologist ensures that the treatment remains appropriate and effective while minimizing risks.
Sources
- [1] Topical clobetasol-17-propionate: review of its clinical efficacy and safety. https://pubmed.ncbi.nlm.nih.gov/3528243/
- [2] Safety of topical corticosteroids in atopic eczema: an umbrella review. https://pubmed.ncbi.nlm.nih.gov/34233978/
- [3] Methylprednisolone aceponate in eczema and other inflammatory skin disorders -- a clinical update. https://pubmed.ncbi.nlm.nih.gov/16409433/
- [4] Topical antibiotics in dermatology. https://pubmed.ncbi.nlm.nih.gov/2972259/
- [5] Glucocorticoids: an enemy or a friend for the dermatologist? recommendations for proper use and safe discontinuation. https://pubmed.ncbi.nlm.nih.gov/42747664/
- [6] Comparative Efficacy of Terbinafine, Itraconazole, and Griseofulvin in Treatment of Steroid-Modified Tinea. https://pubmed.ncbi.nlm.nih.gov/42646662/
- [7] Hydrocortisone 17-butyrate: a new topical corticosteroid preliminary report. https://pubmed.ncbi.nlm.nih.gov/786608/